Lido Advisors
IDXX icon

Lido Advisors’s Idexx Laboratories IDXX Stock Holding History

Lido Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.05M Sell
3,884
-59
-1% -$33.1K 0.01% 791
2026
Q1 		$2.22M Sell
3,943
-132
-3% -$84.6K 0.01% 681
2025
Q4 		$2.68M Buy
4,075
+9
+0.2% +$6.13K 0.01% 630
2025
Q3 		$2.6M Buy
4,066
+2,090
+106% +$1.27M 0.01% 615
2025
Q2 		$1.06M Buy
1,976
+22
+1% +$10.5K ﹤0.01% 817
2025
Q1 		$821K Buy
1,954
+658
+51% +$286K ﹤0.01% 849
2024
Q4 		$536K Sell
1,296
-153
-11% -$67.1K ﹤0.01% 989
2024
Q3 		$732K Sell
1,449
-35
-2% -$17K ﹤0.01% 827
2024
Q2 		$723K Sell
1,484
-135
-8% -$67.8K ﹤0.01% 787
2024
Q1 		$874K Buy
1,619
+113
+8% +$61.8K 0.01% 711
2023
Q4 		$836K Buy
1,506
+3
+0.2% +$1.41K 0.01% 680
2023
Q3 		$657K Buy
1,503
+380
+34% +$189K 0.01% 667
2023
Q2 		$564K Buy
1,123
+301
+37% +$144K ﹤0.01% 693
2023
Q1 		$411K Sell
822
-18
-2% -$8.61K ﹤0.01% 753
2022
Q4 		$343K Buy
840
+136
+19% +$52.8K ﹤0.01% 756
2022
Q3 		$229K Buy
+704
New +$259K ﹤0.01% 851
2022
Q2 		– Sell
-429
Closed -$234K – 997
2022
Q1 		$234K Sell
429
-84
-16% -$44.2K ﹤0.01% 903
2021
Q4 		$337K Buy
+513
New +$322K ﹤0.01% 757
2021
Q1 		– Sell
-682
Closed -$340K – 868
2020
Q4 		$340K Buy
682
+146
+27% +$65.3K 0.01% 582
2020
Q3 		$211K Sell
536
-149
-22% -$55.1K 0.01% 578
2020
Q2 		$226K Buy
+685
New +$198K 0.01% 522
2019
Q3 		– Sell
-1,527
Closed -$420K – 588
2019
Q2 		$420K Buy
1,527
+216
+16% +$53.2K 0.02% 336
2019
Q1 		$293K Buy
+1,311
New +$271K 0.02% 399

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Lido Advisors's IDXX Position: Q2 2026 in Review

Lido Advisors reduced its Idexx Laboratories (IDXX) stake by 1.5% in Q2 2026, selling an estimated $33.1K and leaving 3,884 shares worth $2.05M. The position accounts for 0.01% of the portfolio, ranked #791.

Lido Advisors first reported a position in IDXX in Q1 2019 and has held it in 23 quarters since. The position peaked at $2.68M in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Lido Advisors held 3,884 shares of Idexx Laboratories worth $2.05M as of Q2 2026.
  • Lido Advisors sold 59 Idexx Laboratories shares in Q2 2026, an estimated $33.1K.
  • Idexx Laboratories made up 0.01% of Lido Advisors's portfolio in Q2 2026, its #791 holding.
  • Lido Advisors first reported a position in Idexx Laboratories in Q1 2019 and has held it in 23 quarters since.
  • Lido Advisors's Idexx Laboratories position peaked at $2.68M in Q4 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.